141 related articles for article (PubMed ID: 33800287)
1. 2LTRZFP Interacts Specifically to HIV-1 DNA without Off-Target Effects as Determined by Biolayer Interferometry.
Chupradit K; Thongkum W; Juntit OA; Sornsuwan K; Tayapiwatana C
Biosensors (Basel); 2021 Mar; 11(3):. PubMed ID: 33800287
[TBL] [Abstract][Full Text] [Related]
2. Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions.
Sakkhachornphop S; Jiranusornkul S; Kodchakorn K; Nangola S; Sirisanthana T; Tayapiwatana C
Protein Sci; 2009 Nov; 18(11):2219-30. PubMed ID: 19701937
[TBL] [Abstract][Full Text] [Related]
3. Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration.
Sakkhachornphop S; Barbas CF; Keawvichit R; Wongworapat K; Tayapiwatana C
Hum Gene Ther; 2012 Sep; 23(9):932-42. PubMed ID: 22429108
[TBL] [Abstract][Full Text] [Related]
4. Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study.
Chupradit K; Khamaikawin W; Sakkhachornphop S; Puaninta C; Torbett BE; Borwornpinyo S; Hongeng S; Wattanapanitch M; Tayapiwatana C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216446
[TBL] [Abstract][Full Text] [Related]
5. Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process.
Moonmuang S; Saoin S; Chupradit K; Sakkhachornphop S; Israsena N; Rungsiwiwut R; Tayapiwatana C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30068696
[TBL] [Abstract][Full Text] [Related]
6. Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly.
Khamaikawin W; Saoin S; Nangola S; Chupradit K; Sakkhachornphop S; Hadpech S; Onlamoon N; Ansari AA; Byrareddy SN; Boulanger P; Hong SS; Torbett BE; Tayapiwatana C
Mol Ther Nucleic Acids; 2015 Aug; 4(8):e249. PubMed ID: 26305555
[TBL] [Abstract][Full Text] [Related]
7. A single-step, high throughput, and highly reproducible method for measuring IgM quantity and avidity directly from fish serum via biolayer interferometry (BLI).
Li A; Harris RJ; Fry BG; Barnes AC
Fish Shellfish Immunol; 2021 Dec; 119():231-237. PubMed ID: 34626789
[TBL] [Abstract][Full Text] [Related]
8. Measuring protein-protein and protein-nucleic Acid interactions by biolayer interferometry.
Sultana A; Lee JE
Curr Protoc Protein Sci; 2015 Feb; 79():19.25.1-19.25.26. PubMed ID: 25640894
[TBL] [Abstract][Full Text] [Related]
9. Biolayer interferometry for DNA-protein interactions.
Barrows JK; Van Dyke MW
PLoS One; 2022; 17(2):e0263322. PubMed ID: 35108320
[TBL] [Abstract][Full Text] [Related]
10. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
[TBL] [Abstract][Full Text] [Related]
11. Direct Detection of Low-Molecular-Weight Compounds in 2D and 3D Aptasensors by Biolayer Interferometry.
Vignon A; Flaget A; Michelas M; Djeghdir M; Defrancq E; Coche-Guerente L; Spinelli N; Van der Heyden A; Dejeu J
ACS Sens; 2020 Aug; 5(8):2326-2330. PubMed ID: 32786219
[TBL] [Abstract][Full Text] [Related]
12. Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization.
Concepcion J; Witte K; Wartchow C; Choo S; Yao D; Persson H; Wei J; Li P; Heidecker B; Ma W; Varma R; Zhao LS; Perillat D; Carricato G; Recknor M; Du K; Ho H; Ellis T; Gamez J; Howes M; Phi-Wilson J; Lockard S; Zuk R; Tan H
Comb Chem High Throughput Screen; 2009 Sep; 12(8):791-800. PubMed ID: 19758119
[TBL] [Abstract][Full Text] [Related]
13. Label-free kinetic analysis of an antibody-antigen interaction using biolayer interferometry.
Kumaraswamy S; Tobias R
Methods Mol Biol; 2015; 1278():165-82. PubMed ID: 25859949
[TBL] [Abstract][Full Text] [Related]
14. The strengths and limitations of using biolayer interferometry to monitor equilibrium titrations of biomolecules.
Weeramange CJ; Fairlamb MS; Singh D; Fenton AW; Swint-Kruse L
Protein Sci; 2020 Apr; 29(4):1018-1034. PubMed ID: 31943488
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of testosterone levels with biolayer interferometry.
Zhang H; Li W; Luo H; Xiong G; Yu Y
Chem Biol Interact; 2017 Oct; 276():141-148. PubMed ID: 28532684
[TBL] [Abstract][Full Text] [Related]
16. A novel label-free cell-based assay technology using biolayer interferometry.
Verzijl D; Riedl T; Parren PWHI; Gerritsen AF
Biosens Bioelectron; 2017 Jan; 87():388-395. PubMed ID: 27589401
[TBL] [Abstract][Full Text] [Related]
17. BLI-MS: Combining biolayer interferometry and mass spectrometry.
Jung V; Roger K; Chhuon C; Pannetier L; Lipecka J; Gomez JS; Chappert P; Charbit A; Guerrera IC
Proteomics; 2022 May; 22(9):e2100031. PubMed ID: 34958708
[TBL] [Abstract][Full Text] [Related]
18. Binding of the eukaryotic translation elongation factor 1A with the 5'UTR of HIV-1 genomic RNA is important for reverse transcription.
Li D; Wei T; Jin H; Rose A; Wang R; Lin MH; Spann K; Harrich D
Virol J; 2015 Aug; 12():118. PubMed ID: 26242867
[TBL] [Abstract][Full Text] [Related]
19. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
